What is the typical starting dose of Adderall (amphetamine and dextroamphetamine) for a patient with attention deficit hyperactivity disorder (ADHD) or narcolepsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adderall Starting Dose

For adults with ADHD, start Adderall at 5 mg once daily in the early morning, with a noon dose added if the effect does not last through the school or work day, then titrate upward in 5-10 mg weekly increments until symptoms are controlled. 1, 2

Starting Dose by Age Group

Adults and Older Adolescents

  • Begin with 5 mg of immediate-release amphetamine/dextroamphetamine given once daily in the early morning 1, 2
  • Add a noon dose of 5 mg if the morning dose does not provide coverage through the functional day 1
  • For extended-release formulations, start at 10 mg once daily in the morning 2

Children (Ages 6 and Older)

  • Start with 5 mg once or twice daily 3
  • Administer the first dose upon awakening, with additional doses at 4-6 hour intervals if needed 3

Young Children (Ages 3-5)

  • Start with 2.5 mg daily 3
  • This lower starting dose accounts for smaller body size and increased sensitivity to stimulant effects 3

Adolescents (Ages 13-17)

  • Begin with 10 mg once daily in the morning for extended-release formulations 4
  • For immediate-release, follow the adult dosing of 5 mg once or twice daily 1

Titration Protocol

Weekly Dose Escalation

  • Increase by 5-10 mg increments weekly based on symptom control and tolerability 1, 2
  • Wait at least one full week between dose adjustments to properly evaluate response 1, 2
  • Continue titration until optimal symptom control is achieved or side effects become limiting 1, 2

Monitoring During Titration

  • Obtain standardized ADHD rating scales from the patient (and significant other for adults, or teachers/parents for children) before each dose increase 1, 2
  • Systematically assess for side effects at each adjustment, particularly appetite suppression, insomnia, blood pressure elevation, and agitation 1, 2
  • Monitor blood pressure and pulse at each dose adjustment 2

Target Dose Range

Adults

  • Most adults achieve optimal response at total daily doses of 40-60 mg 5, 2
  • The maximum recommended dose is 40 mg for immediate-release amphetamine salts 5, 3
  • Extended-release formulations have a maximum recommended dose of 50 mg daily 5
  • Some patients may require doses up to 60 mg daily when symptoms cannot be controlled at lower levels, though this should be carefully documented 1, 5

Children and Adolescents

  • Rarely necessary to exceed 40 mg total daily dose in children 3
  • Adolescents in clinical trials showed efficacy with doses ranging from 10-40 mg daily 4

Dosing Schedule Considerations

Timing of Administration

  • Always administer the first dose upon awakening or with breakfast 1, 2
  • If using immediate-release formulations, give additional doses at 4-6 hour intervals 3
  • Avoid doses after 2:00 PM to minimize sleep disturbances 1

Multiple Daily Doses

  • Adults typically require 2-3 doses daily with immediate-release formulations to cover a longer functional day 2
  • Extended-release formulations are dosed once daily in the morning 2, 4

Special Population Dosing

Narcolepsy

  • For adults and adolescents 12 years and older, start with 10 mg daily 3
  • Increase in 10 mg increments weekly until optimal response is obtained 3
  • Usual dose range is 5-60 mg per day in divided doses 3
  • For children ages 6-12 with narcolepsy, start with 5 mg daily and increase in 5 mg increments weekly 3

Medically Ill Patients

  • Use approximately one-half the standard starting dose for ADHD (2.5 mg) when treating apathy or depression in medically ill patients 1
  • Titrate slowly with careful monitoring for side effects 1

Critical Monitoring Requirements

Baseline Assessment

  • Obtain baseline blood pressure, pulse, height, and weight before initiating treatment 2
  • Document baseline ADHD symptom severity using standardized rating scales 1, 2

Ongoing Monitoring

  • Assess blood pressure, pulse, height, and weight at each visit 2
  • Use standardized ADHD rating scales to objectively track response 1, 2
  • Systematically evaluate both target symptoms and side effects at each dose adjustment 5, 2

Common Pitfalls to Avoid

Starting Too High

  • Starting at doses higher than 5 mg (or 2.5 mg in young children) leads to unnecessary side effects and decreased adherence 5, 2
  • The lower starting dose allows assessment of individual response while minimizing initial adverse effects 2

Inadequate Time Between Adjustments

  • Failing to wait at least one week between dose increases prevents proper evaluation of response 1, 2
  • Premature dose escalation increases the risk of overshooting the optimal dose 2

Poor Timing of Doses

  • Administering doses too late in the day (after 2:00 PM) significantly increases sleep disturbances 1, 2
  • Morning administration is essential regardless of formulation 2

Continuing Escalation Without Benefit

  • If approaching 40-50 mg without adequate symptom control, switch to an alternative stimulant rather than continuing to increase the dose 5, 2
  • Approximately 70% of patients respond to either amphetamine or methylphenidate alone, but nearly 90% will respond if both are tried 5

Inadequate Systematic Assessment

  • Failing to use standardized rating scales and relying solely on subjective impressions leads to suboptimal dosing decisions 1, 2
  • Objective measurement is essential for determining optimal dose 1, 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.